Other Clinical Trial - Prognostic Model of GC/TAC in the Treatment of MN

Status Not yet recruiting

Clinical Trial Summary

The goal of this observational study is to explore the factors that can predict the prognosis difference in patients with idiopathic membranous nephropathy (IMN) under the treatment of glucocorticoid + tacrolimus. The main questions it aims to answer are: - to explore the factors that can predict the prognosis difference in patients with IMN under the treatment of glucocorticoid + tacrolimus - to establish a clinical prediction model and verify it to provide a reference for the early Participants will receive standard the treatment of glucocorticoid + tacrolimus treatment and will then be divided into remission and non remission groups based on the treatment effect after the standard treatment cycle. Blood, urine, and fecal samples were collected from patients to explore possible factors influencing treatment efficacy. Researchers will compare [remission group and non-remission group] to see if the gut microbiota and its metabolites are factors that influence the efficacy of treatment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Glomerulonephritis, Membranous
Idiopathic Membranous Nephropathy
Kidney Diseases

Clinical Trial Details

NCT number	NCT05667896
Study type	Observational [Patient Registry]
Source	Qianfoshan Hospital
Contact
Status	Not yet recruiting
Phase
Start date	June 2023
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06245707` - the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy	N/A
Recruiting	`NCT03864250` - Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy	N/A
Completed	`NCT01180036` - MEmbranous Nephropathy Trial Of Rituximab	Phase 2/Phase 3
Completed	`NCT01845688` - Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy	N/A
Withdrawn	`NCT01093781` - Aliskiren in Patients With Idiopathic Membranous Nephropathy	N/A
Completed	`NCT00362531` - Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome	Phase 2/Phase 3
Recruiting	`NCT05839314` - Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy	Phase 4
Completed	`NCT00302523` - Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy	N/A
Terminated	`NCT03466801` - The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.	N/A
Terminated	`NCT03475602` - Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy
Not yet recruiting	`NCT05850845` - Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN
Not yet recruiting	`NCT05667909` - Prognostic Model of Rituximab in the Treatment of MN
Not yet recruiting	`NCT05667922` - Prognostic Model of TAC in the Treatment of MN
Not yet recruiting	`NCT05667883` - Prognostic Model of GC/CTX in the Treatment of MN
Recruiting	`NCT02173106` - A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy	Phase 2
Completed	`NCT01161459` - Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid	N/A
Recruiting	`NCT03549663` - Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)	N/A
Not yet recruiting	`NCT05845762` - Obinutuzumab in the Management of Idiopathic Membranous Nephropathy
Completed	`NCT00694863` - Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy	Phase 2
Recruiting	`NCT03170323` - Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy	Phase 4